Rephonic
Artwork for The Lancet Primary Care in conversation with

The Lancet Primary Care in conversation with

The Lancet Group
Primary Care
Rural Health
Fecal Immunochemical Test
Hermes Trial
Alzheimer's Disease
Relational Care
Post-Covid-19 Condition
Glucagon-Like Peptide 1 Receptor Agonists
Health Equity
Teleophthalmology
Long COVID
Harvard University
Queen Mary University Of London
Rural Health Compass
Europe
United Kingdom
Mortality
Artificial Intelligence In Ophthalmology
Anti-Amyloid Therapies
Cost-Effectiveness

Explore the latest primary care research and topics with The Lancet Primary Care In conversation with. Journal editors speak to community members, primary care professionals, academics, and other individuals involved in the field, with the aim of improving health, health care, and health policy for people worldwide.

PublishesMonthlyEpisodes13Foundeda year ago
Number of ListenersCategories
Health & FitnessMedicine

Listen to this Podcast

Artwork for The Lancet Primary Care in conversation with

Latest Episodes

Giuliano Russo, Martin McKee, and Sulakshana Nandi discuss their Health Policy paper exploring the scale of, drivers of, and solutions to general practice shortages in Europe, including the roles of academics and policy makers, potential future resea... more

Thijs Jansz and John Dennis discuss their Article exploring the comparative effectiveness of GLP-1 receptor agonists versus other agents for kidney outcomes in individuals with type 2 diabetes taking SGLT2 inhibitors, including real-world implication... more

Sara Riggare and Joshua Biro discuss the current landscape and potential future directions of AI in primary care, including how it can empower patients, how we can see more human–AI collaboration, and how these aspects, alongside others, can affect p... more

Alike van der Velden, Marta Wanat, and Christopher Butler discuss the PRUDENCE trial, which assessed the ability of a point-of-care testing strategy to reduce antibiotic prescribing for acute respiratory tract infections in primary care. The trial in... more

Erica Fong and Sarah Beale discuss their Lancet Primary Care Article on the effects of post-COVID-19 condition on daily functional activities, including the implications of their findings for real-world primary care and for future research and policy... more

Professor Dame Tina Lavender discusses her Lancet Primary Care Viewpoint regarding meaningful relational maternity care in low-income and middle-income countries, including barriers and facilitators, workforce training, and implications on subsequent... more

Professor Dame Louise Robinson discusses her Lancet Primary Care Viewpoint regarding primary care perspectives on the new therapeutic era for Alzheimer’s disease, including implications for the health-care workforce, the potential for use around the ... more

Konstantinos Balaskas and Anitta Sharma discuss the HERMES trial, a cluster-randomised controlled trial investigating teleophthalmology innovations versus standard of care, including real-world implications of the AI involved and potential directions... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

NEJM Interviews
NEJM InterviewsNEJM Group

Recent Guests

Giuliano Russo
Senior Lecturer of Global Health
Queen Mary University of London
Episode: Giuliano Russo, Martin McKee, and Sulakshana Nandi on the general practice workforce crisis in Europe
Martin McKee
Professor of European Public Health
London School of Hygiene and Tropical Medicine
Episode: Giuliano Russo, Martin McKee, and Sulakshana Nandi on the general practice workforce crisis in Europe
Sulakshana Nandi
Technical Officer on Human Resources for Health
WHO European Regional Office
Episode: Giuliano Russo, Martin McKee, and Sulakshana Nandi on the general practice workforce crisis in Europe
Thijs Jansz
Academic clinical lecturer and kidney doctor; University of Exeter
University of Exeter
Episode: Thijs Jansz and John Dennis on GLP-1 receptor agonists for kidney outcomes in people with type 2 diabetes
John Dennis
Associate professor of health data science; University of Exeter
University of Exeter
Episode: Thijs Jansz and John Dennis on GLP-1 receptor agonists for kidney outcomes in people with type 2 diabetes
Sara Riggare
Researcher focused on patient knowledge and self-care in chronic disease; co-director of the Center for Disability Research at Uppsala University
Uppsala University
Episode: Sara Riggare and Joshua Biro on AI in primary care
Joshua Biro
Research scientist at MedStar Health; Assistant Professor at Georgetown University; expert in cognitive systems engineering and AI safety in healthcare
MedStar Health; Georgetown University
Episode: Sara Riggare and Joshua Biro on AI in primary care
Alike van der Velden
Senior researcher, coordinating investigator of Prudence
University Medical Center Utrecht
Episode: Alike van der Velden, Marta Wanat, and Christopher Butler on the PRUDENCE trial
Marta Wanat
Senior qualitative researcher in behavioral science
University of Oxford
Episode: Alike van der Velden, Marta Wanat, and Christopher Butler on the PRUDENCE trial

Host

Lauren Southwell
Host of In Conversation With

Talking Points

Recent interactions between the hosts and their guests.

Yaiza del Pozo Martín, Jessica Smith, and Lauren Southwell on The Lancet Primary Care
Q: Yaiza, maybe you could tell us a bit more about the aims and scope of the journal?
The Lancet Primary Care is a global, independent, open-access journal focusing on primary care and community health. It aims to publish research and opinion that inform clinical practice and policy, improve equity in access, and explore system-level approaches to organizing primary and community care around the world.
Konstantinos Balaskas and Anitta Sharma on the HERMES trial
Q: What are the key factors limiting AI performance in this context and how could they be addressed?
AI tends to be over-enthusiastic in referring more patients; improvements require broader inputs beyond images (clinical data, symptoms), training on diverse devices, and alignment with real-world referral rules that evolve with guidelines.
Konstantinos Balaskas and Anitta Sharma on the HERMES trial
Q: Could you please tell us more about how these processes work and why you evaluated them in tandem?
The Hermes trial aimed to ease pressures in crowded eye clinics by bringing hospital expertise into the community, with remote review of scans within 48 hours and an AI model to assist referrals, evaluated together to see how the combined pathway performs in real life.
Dame Louise Robinson on the new therapeutic era for Alzheimer’s disease
Q: What are the mechanisms and the journey of anti-amyloid therapies up to this point?
Anti-amyloid therapies aim to remove amyloid plaques from the brain; they represent a shift from symptomatic treatment to disease-modifying approaches, though early results show modest benefits and require careful consideration of risks, biomarker confirmation, and healthcare infrastructure.
Dame Louise Robinson on the new therapeutic era for Alzheimer’s disease
Q: First of all, how did the viewpoint come to be and why now?
The viewpoint was written to include primary care perspectives in a broader expert consensus series, recognizing that most people with dementia are managed in primary care and to address gaps in primary care literature amidst emerging therapies and biomarkers.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

This program features in-depth conversations with leading researchers, clinicians, and editors focusing on primary care research, policy, and practice. Episodes cover real-world studies, trials, and innovations in primary care—from AI and digital health to antimicrobial stewardship, long COVID, dementia care, maternal health, and eye care—with an emphasis on practical implications for patients, providers, and health systems. Notable strengths include a strong academic and clinical mix among guests, a focus on implementation and real-world impact, and clear discussions on how new evidence translates into primary care practice and policy. Potential listeners who want evidence-informed perspectives on primary care, health technology, and globa... more

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. NEJM Interviews

How many episodes of this podcast are there?

this podcast launched a year ago and published 13 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Giuliano Russo
2. Martin McKee
3. Sulakshana Nandi
4. Thijs Jansz
5. John Dennis
6. Sara Riggare
7. Joshua Biro
8. Alike van der Velden

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days